MHRA and HRA coordinated pathway for medical devices

Medical Devices have for some time felt like a bit of an overlooked area in UK research regulation, always seeming to lag behind some of the innovative approaches that have been developed for other types of research (and creating a confusing situation for manufacturers and sponsors to navigate).

The announcement of a coordinated pathway for MHRA and REC review will hopefully help to simplify and streamline approvals like the combined review has for CTIMPs.

The government announcement can be read here, which includes the details of how the access the service.

Previous
Previous

One-stop-shop for AI and digital regulations for health and social care launched

Next
Next

ECMC Network response to Lord O’Shaughessy review